Role of procalcitonin in infected diabetic foot ulcer

Jung-Ho Park, Dong Hun Suh, Hak Jun Kim, Yong In Lee, Il Hoon Kwak, Gi Won Choi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aims Procalcitonin (PCT) has been recently accepted as a marker for diagnosing infection. The aim of the present study was to determine whether PCT levels are associated with infection severity of diabetic foot ulcers and whether PCT levels would be helpful to differentiate infected diabetic foot ulcer (IDFU) from IDFU associated with other infectious diseases (IDFU + O). Methods We prospectively included 123 diabetic patients hospitalized for IDFU. Infection severity of diabetic foot ulcers was graded according to the Infectious Diseases Society of America-International Working Group on the Diabetic Foot clinical classification of diabetic foot infection. Chest radiograph, urinalysis, urine microscopy, urine culture, and blood cultures (if fever was present) were performed for all patients to diagnose other infectious diseases. Laboratory parameters were measured from blood venous samples. Results PCT (Spearman's ρ = 0.338, P < 0.001) and C-reactive protein (Spearman's ρ = 0.477, P < 0.001) levels were significantly associated with infection severity of diabetic foot ulcers. However, only PCT levels could differentiate patients with associated infectious diseases from patients with no concomitant infection (area under the receiver-operator characteristic curve 0.869, P < 0.0001; cut-off value 0.59; sensitivity 94.7; specificity 88.5). Conclusion PCT and CRP levels positively correlated with infection severity of diabetic foot ulcers and PCT levels > 0.59 ng/mL in patients with IDFU may be associated with other systemic bacterial infection.

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalDiabetes Research and Clinical Practice
Volume128
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Diabetic Foot
Calcitonin
Infection
Communicable Diseases
Urine
Urinalysis
Bacterial Infections
Microscopy
Fever
Thorax

Keywords

  • Diabetic foot
  • Infection
  • Procalcitonin
  • Ulcer

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Role of procalcitonin in infected diabetic foot ulcer. / Park, Jung-Ho; Suh, Dong Hun; Kim, Hak Jun; Lee, Yong In; Kwak, Il Hoon; Choi, Gi Won.

In: Diabetes Research and Clinical Practice, Vol. 128, 01.06.2017, p. 51-57.

Research output: Contribution to journalArticle

@article{bdf760fa1b1e4d6e92c5db1baef325f8,
title = "Role of procalcitonin in infected diabetic foot ulcer",
abstract = "Aims Procalcitonin (PCT) has been recently accepted as a marker for diagnosing infection. The aim of the present study was to determine whether PCT levels are associated with infection severity of diabetic foot ulcers and whether PCT levels would be helpful to differentiate infected diabetic foot ulcer (IDFU) from IDFU associated with other infectious diseases (IDFU + O). Methods We prospectively included 123 diabetic patients hospitalized for IDFU. Infection severity of diabetic foot ulcers was graded according to the Infectious Diseases Society of America-International Working Group on the Diabetic Foot clinical classification of diabetic foot infection. Chest radiograph, urinalysis, urine microscopy, urine culture, and blood cultures (if fever was present) were performed for all patients to diagnose other infectious diseases. Laboratory parameters were measured from blood venous samples. Results PCT (Spearman's ρ = 0.338, P < 0.001) and C-reactive protein (Spearman's ρ = 0.477, P < 0.001) levels were significantly associated with infection severity of diabetic foot ulcers. However, only PCT levels could differentiate patients with associated infectious diseases from patients with no concomitant infection (area under the receiver-operator characteristic curve 0.869, P < 0.0001; cut-off value 0.59; sensitivity 94.7; specificity 88.5). Conclusion PCT and CRP levels positively correlated with infection severity of diabetic foot ulcers and PCT levels > 0.59 ng/mL in patients with IDFU may be associated with other systemic bacterial infection.",
keywords = "Diabetic foot, Infection, Procalcitonin, Ulcer",
author = "Jung-Ho Park and Suh, {Dong Hun} and Kim, {Hak Jun} and Lee, {Yong In} and Kwak, {Il Hoon} and Choi, {Gi Won}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.diabres.2017.04.008",
language = "English",
volume = "128",
pages = "51--57",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Role of procalcitonin in infected diabetic foot ulcer

AU - Park, Jung-Ho

AU - Suh, Dong Hun

AU - Kim, Hak Jun

AU - Lee, Yong In

AU - Kwak, Il Hoon

AU - Choi, Gi Won

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Aims Procalcitonin (PCT) has been recently accepted as a marker for diagnosing infection. The aim of the present study was to determine whether PCT levels are associated with infection severity of diabetic foot ulcers and whether PCT levels would be helpful to differentiate infected diabetic foot ulcer (IDFU) from IDFU associated with other infectious diseases (IDFU + O). Methods We prospectively included 123 diabetic patients hospitalized for IDFU. Infection severity of diabetic foot ulcers was graded according to the Infectious Diseases Society of America-International Working Group on the Diabetic Foot clinical classification of diabetic foot infection. Chest radiograph, urinalysis, urine microscopy, urine culture, and blood cultures (if fever was present) were performed for all patients to diagnose other infectious diseases. Laboratory parameters were measured from blood venous samples. Results PCT (Spearman's ρ = 0.338, P < 0.001) and C-reactive protein (Spearman's ρ = 0.477, P < 0.001) levels were significantly associated with infection severity of diabetic foot ulcers. However, only PCT levels could differentiate patients with associated infectious diseases from patients with no concomitant infection (area under the receiver-operator characteristic curve 0.869, P < 0.0001; cut-off value 0.59; sensitivity 94.7; specificity 88.5). Conclusion PCT and CRP levels positively correlated with infection severity of diabetic foot ulcers and PCT levels > 0.59 ng/mL in patients with IDFU may be associated with other systemic bacterial infection.

AB - Aims Procalcitonin (PCT) has been recently accepted as a marker for diagnosing infection. The aim of the present study was to determine whether PCT levels are associated with infection severity of diabetic foot ulcers and whether PCT levels would be helpful to differentiate infected diabetic foot ulcer (IDFU) from IDFU associated with other infectious diseases (IDFU + O). Methods We prospectively included 123 diabetic patients hospitalized for IDFU. Infection severity of diabetic foot ulcers was graded according to the Infectious Diseases Society of America-International Working Group on the Diabetic Foot clinical classification of diabetic foot infection. Chest radiograph, urinalysis, urine microscopy, urine culture, and blood cultures (if fever was present) were performed for all patients to diagnose other infectious diseases. Laboratory parameters were measured from blood venous samples. Results PCT (Spearman's ρ = 0.338, P < 0.001) and C-reactive protein (Spearman's ρ = 0.477, P < 0.001) levels were significantly associated with infection severity of diabetic foot ulcers. However, only PCT levels could differentiate patients with associated infectious diseases from patients with no concomitant infection (area under the receiver-operator characteristic curve 0.869, P < 0.0001; cut-off value 0.59; sensitivity 94.7; specificity 88.5). Conclusion PCT and CRP levels positively correlated with infection severity of diabetic foot ulcers and PCT levels > 0.59 ng/mL in patients with IDFU may be associated with other systemic bacterial infection.

KW - Diabetic foot

KW - Infection

KW - Procalcitonin

KW - Ulcer

UR - http://www.scopus.com/inward/record.url?scp=85018576338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018576338&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2017.04.008

DO - 10.1016/j.diabres.2017.04.008

M3 - Article

C2 - 28448892

AN - SCOPUS:85018576338

VL - 128

SP - 51

EP - 57

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

ER -